These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2841022)

  • 41. Recent advances in etoposide therapy for non-small cell lung cancer.
    Bonomi P
    Cancer; 1991 Jan; 67(1 Suppl):254-9. PubMed ID: 1845849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I study of a carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer.
    Nakano H; Tsuchiya S; Takei Y; Minato K; Watanabe S; Makimoto T; Naruse I; Nomoto T; Ishihara S; Takise A; Ezawa K; Fueki N; Hoshino H; Saito R; Mori M
    Am J Clin Oncol; 1996 Jun; 19(3):245-8. PubMed ID: 8638534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carboplatin/etoposide in small cell lung cancer.
    Bishop JF
    Oncology; 1992; 49 Suppl 1():11-7; discussion 17-8. PubMed ID: 1323807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platinum/oral etoposide therapy in non-small cell lung cancer.
    Furuse K
    Oncology; 1992; 49 Suppl 1():63-9; discussion 70. PubMed ID: 1323814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of radiotherapy of lung cancer].
    Mardynskiĭ IuS; Zolotkov AG; Kudriavtsev DV
    Vopr Onkol; 2006; 52(5):499-504. PubMed ID: 17168355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In regard to hyperfractionation for non-small-cell lung cancer: fire, ready, aim!
    Beitler JJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1460; author reply 1460-1. PubMed ID: 12654462
    [No Abstract]   [Full Text] [Related]  

  • 47. [Phase II study of combination chemotherapy with cisplatin, carboplatin and etoposide (CPVP) in unresectable non-small cell lung cancer: analysis of survival time and prognostic factors].
    Sakurai M; Ichiki M; Hayashi I
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):303-8. PubMed ID: 9051132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].
    Yanagawa H; Bando H; Takishita Y; Shinohara T; Tanaka H
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1403-5. PubMed ID: 1323959
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chemotherapy with oral etoposide, UFT and carboplatin in non-small cell lung cancer].
    Kinoshita T; Akaogi E; Mitsui K; Onizuka M; Ishikawa S; Morita R; Ishibashi O; Suga M; Inagaki M; Okazaki H
    Gan To Kagaku Ryoho; 1994 May; 21(6):891-4. PubMed ID: 8185351
    [No Abstract]   [Full Text] [Related]  

  • 50. Trimetrexate combined with cisplatin or etoposide in the treatment of non-small cell lung cancer: a pilot study.
    Maroun JA; Natale RB; Robert F
    Semin Oncol; 1988 Apr; 15(2 Suppl 2):38-40. PubMed ID: 2835818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lung.
    Schiller JH; Storer B; Dreicer R; Rosenquist D; Frontiera M; Carbone PP
    J Natl Cancer Inst; 1989 Nov; 81(22):1739-43. PubMed ID: 2553993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
    Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC
    Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platinum/etoposide therapy in non-small cell lung cancer.
    Bonomi P
    Oncology; 1992; 49 Suppl 1():43-50. PubMed ID: 1323811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combination chemotherapy of CDDP and etoposide in advanced non-small cell carcinoma of the lung].
    Kodama N; Furuse K; Kawahara M; Arai R; Yamamoto M; Tsuruta M; Kubota K; Ogawara M; Nakai R; Kawano S
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3233-7. PubMed ID: 2848457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
    Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy consisting of epirubicin, cisplatin, and etoposide followed by irradiation in stage III non-small cell lung cancer and chemotherapy alone in stage IV non-small cell lung cancer.
    Wils J; Utama I; Smeets J
    Oncology; 1988; 45(6):413-6. PubMed ID: 2847098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboplatin and etoposide as outpatient treatment of advanced non-small-cell lung cancer.
    Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
    Chemotherapy; 1994; 40(2):144-8. PubMed ID: 8131636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trials referral resource. Non-small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1992 Jul; 6(7):44, 49-50. PubMed ID: 1322153
    [No Abstract]   [Full Text] [Related]  

  • 59. Lung cancer--time to move on from chemotherapy.
    Carney DN
    N Engl J Med; 2002 Jan; 346(2):126-8. PubMed ID: 11784881
    [No Abstract]   [Full Text] [Related]  

  • 60. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Saito R; Tsuchiya S; Minato K; Ishizuka T
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):744-51. PubMed ID: 2841389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.